V900654
2,3-Diaminopyridine
Vetec™, reagent grade, 94%
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Empirical Formula (Hill Notation):
C5H7N3
CAS Number:
Molecular Weight:
109.13
Beilstein:
109869
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
Pricing and availability is not currently available.
grade
reagent grade
product line
Vetec™
Assay
94%
mp
110-115 °C (lit.)
SMILES string
Nc1cccnc1N
InChI
1S/C5H7N3/c6-4-2-1-3-8-5(4)7/h1-3H,6H2,(H2,7,8)
InChI key
ZZYXNRREDYWPLN-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Legal Information
Vetec is a trademark of Merck KGaA, Darmstadt, Germany
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nessreen A Al-Hashimi
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 60(8-9), 2181-2184 (2004-07-14)
The charge-transfer interaction of 2,3-diaminopyridine (DAPY) and iodine has been investigated spectrophotometrically in the solvents chloroform and dichloromethane at room temperature. The results indicate the formation of 1:2 charge-transfer complex in each solvent with the observation of the two characteristic
Xiangyang Shi et al.
Electrophoresis, 26(15), 2949-2959 (2005-07-05)
Generation 2 to generation 5 poly(amidoamine) (PAMAM) dendrimers having different terminal functionalities were analyzed by capillary electrophoresis (CE). Polyacrylamide gel electrophoresis was also used to assess the composition of the individual generations for comparison with the CE results. Separation of
Scott D Kuduk et al.
Journal of medicinal chemistry, 47(26), 6439-6442 (2004-12-14)
Bradykinin B1 receptor antagonists embody a potentially novel approach for the treatment of chronic pain and inflammation. A series of 2,3-diaminopyridine B1 antagonists was optimized to have sub-nanomolar affinity and good pharmacokinetic properties. Lead compounds were shown to exhibit good
Dong-Mei Feng et al.
Bioorganic & medicinal chemistry letters, 15(9), 2385-2388 (2005-04-20)
A novel class of 2,3-diaminopyridine bradykinin B1 receptor antagonists is disclosed. Structure-activity relationship studies (SARs) that led to compounds with significantly improved potency and pharmacokinetic properties relative to the lead compound are described.
G E Kirsch et al.
The Journal of pharmacology and experimental therapeutics, 226(1), 174-179 (1983-07-01)
Aminopyridines, potent potassium channel blocking agents, were studied for their site of action and active form in the nerve membrane. Voltage clamped, internally perfused squid giant axons were used. 3,4-Diaminopyridine, one of the most potent aminopyridine derivatives, blocked the potassium
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
